Bifenestral surgical and chemical labyrinthectomy, a new effective ablative surgical approach to intractable vertigo in Ménière disease elderly patients / Laberintectomía química y quirúrgica bifenestral, una nueva técnica ablativa eficaz para el vértigo intratable en pacientes ancianos con enfermedad de Ménière

Introduction In this article, the bi-fenestral surgical chemical labyrinthectomy is introduced as a surgical demolition technique for treating resisting incurable forms of Meniere’s disease in patients aged over 70 and/or with low hearing residues refractory to medical treatment. Materials and methods The results on participants fitting the inclusion criteria (n = 16) were reported using anamnesis (frequency of the crisis), Dizziness Handicap Inventory (DHI) and Functional Level Scale (FLS) before and after the intervention. Results Vertigo control was achieved in all patients of this case series. A difference of 57 and 3.67 in mean DHI (from 68 (SD 16.7) to 11 (SD 14)) and FLS (from 4.68 (SD 0.7) to 0.1 (SD 0.3)) scores respectively were seen after an average of 16.28 months. Contextually tinnitus was reported to improve in seven patients (43.75%), aggravate in three (18.75%) and remain unchanged in the remaining six (37.5%). Conclusion Bi-fenestral surgical chemical labyrinthectomy appears a safe, immediate, and effective demolition treatment for vertigo control in a restricted class of patients affected by intractable Meniere disease. (AU)

Introducción En este artículo se presenta la laberintectomía química quirúrgica bifenestral como técnica quirúrgica de demolición para el tratamiento de formas resistentes e incurables de la enfermedad de Meniere en pacientes mayores de 70 años y/o con baja audición refractaria al tratamiento médico. Materiales y métodos Los resultados de los participantes que cumplieron con los criterios de inclusión (n = 16) se informaron mediante anamnesis (frecuencia de las crisis), Dizziness Handicap Inventory (DHI) y Functional Level Scale (FLS) antes y después de la intervención. Resultados Se logró el control del vértigo en todos los pacientes de esta serie de casos. Una diferencia de 57 y 3,67 en las puntuaciones medias de DHI (de 68 (DE 16,7) a 11 (DE 14)) y FLS (de 4,68 (DE 0,7) a 0,1 (DE 0,3)) respectivamente fueron vistos después de un promedio de 16,28 meses. Contextualmente, se informó que el tinnitus mejoró en siete pacientes (43,75%), se agravó en tres (18,75 %) y permaneció sin cambios en los seis restantes (37,5%). Conclusión La laberintectomía química quirúrgica bifenestral parece un tratamiento de demolición seguro, inmediato y efectivo para el control del vértigo en una clase restringida de pacientes afectados por la enfermedad de Meniere intratable. (AU)

Vértigo posicional paroxístico benigno y enfermedad de Menière: análisis retrospectivo / Benign paroxysmal positional vertigo and Menière's disease: retrospective analysis

Introducción y objetivo: El Vértigo Posicional Paroxístico Benigno (VPPB) es más frecuente dentro del subgrupo de pacientes con Enfermedad de Menière (EM). El presente estudio tiene como objetivo describir las características clínicas tanto del VPPB como de la EM cuando se encuentran asociados. Método: Realizamos un análisis retrospectivo de 22 pacientes con EM diagnosticados de VPPB entre el 1999 y el 2021 en el Complejo Asistencial Universitario de Salamanca. Se recogieron variables clínicas, tanto de las características del VPPB como de la EM. Resultados: En nuestra base de datos, el 66,66 % de los 22 pacientes eran mujeres con una edad media de 59,33 años. El canal semicircular afecto con más frecuencia fue el posterior derecho. En cuanto al VPPB, un 19% se trata de VPPB multicanal, en casi la mitad (47,62%) se tuvieron que realizar más de tres maniobras para solucionarlo y tardó más de un mes en resolverse en más de la mitad (57,14%). Por otro lado, la EM era bilateral en el 19% de los pacientes, con un tiempo de evolución desde el diagnóstico de más de tres años en el 71,42%. Un tercio de los pacientes había presentado más de 10 crisis en los últimos seis meses, y fluctuación en la audición. En base a estos resultados, parece que los pacientes con EM avanzada tienen más probabilidades de presentar VPPB y con peor resultado en su tratamiento. Conclusión: La aparición conjunta del VPPB y la EM podría afectar al pronóstico de ambas patologías por separado. (AU)

Introuction and objective: Benign Paroxysmal Positional Vertigo (BPPV) is more frequent within the subgroup of patients with Menière's Disease (MD). The present study aims to describe the clinical characteristics of both BPPV and MD, when they are associated. Method: We carried out a retrospective analysis of 22 patients with MD diagnosed with BPPV between 1999 and 2021 at the University Assistance Complex of Salamanca. Clinical variables were collected, both from the characteristics of BPPV and MD. Results: In our database, 66.66% of the 22 patients were women with a mean age of 59.33 years. The most frequently affected semicircular canal was the posterior right. Regarding BPPV, 19% are multichannel BPPV, in almost half (47.62%) more than three maneuvers had to be performed to solve it and it took more than a month to resolve it in more than half (57.14%). On the other hand, MD was bilateral in 19% of patients, with a time since diagnosis of more than three years in 71.42%. A third of the patients had presented more than 10 crises in the last six months, and fluctuation in hearing. Based on these results, it appears that patients with advanced MD are more likely to have BPPV and have a worse treatment outcome. Conclusion: The joint appearance of BPPV and MD could affect the prognosis of both pathologies separately. (AU)

Tinnitus characteristics in patients with hyperacusis and vertigo (including Ménière's disease) vs. hyperacusis alone.

INTRODUCTION AND OBJECTIVES: To compare clinical and psychoacoustic tinnitus characteristics in patients with the comorbidity of hyperacusis, hyperacusis and vertigo, and with Ménière's disease (MD). MATERIALS AND METHODS: Three hundred and twenty-nine tinnitus patients underwent audiological and otoneurological evaluation. Records of 94 individuals younger than 65 years, 40 women and 54 men (mean age 41.8, range 24-64 years), who complained of tinnitus and hyperacusis, were analyzed. One hundred and thirty-one ears with tinnitus were identified: 67 in the group of patients with tinnitus and hyperacusis (group 1; 41 patients); 28 in the group fulfilling criteria of MD diagnosis (group 2; 28); and 36 in the group with tinnitus, hyperacusis and typical symptoms of vertigo (group 3; 25). RESULTS AND CONCLUSIONS: Mean value of interaural difference in canal paresis in group 1 was 6.3%; in group 2: 23.7%; and in group 3: 25.9%; p<.001. Mean tinnitus pitch value was significantly lower in group 3 (1679Hz; SD=1139) and group 2 (2250Hz; SD=1162) compared to group 1 (4538Hz; SD=3123; p=.012). Values of tinnitus intensity and other characteristics did not significantly differ between the groups. Tinnitus and hyperacusis were most frequently preceded by acoustic trauma. Tinnitus coinciding with hyperacusis and vertigo was observed in patients after head trauma. Mean tinnitus pitch was lower in the groups of patients with hyperacusis and peripheral labyrinthine lesion than in tinnitus sufferers with hyperacusis alone. Tinnitus sufferers with low tinnitus pitch should undergo vestibular system evaluation. Hyperacusis and vertigo are likely comorbidities in tinnitus patients after head trauma. Hyperacusis may coincide in tinnitus patients after head trauma.

Umbrales auditivos en pacientes con enfermedad de Méniere manejados con corticoides transtimpánicos / Hearing thresholds in Ménière's disease patients managed with transtympanic dexametasone

Introducción: Pese a que el uso de corticoides transtimpánicos en pacientes con enfermedad de Méniere es habitual en muchos centros, la evidencia respecto de su efecto sobre los umbrales auditivos es aún controversial. Objetivo: Estudiar los umbrales auditivos de pacientes con enfermedad de Méniere que recibieron corticoides transtimpánicos en el Servicio de Otorrinolaringología del Hospital Clínico de la Universidad de Chile. Material y Método: Estudio retrospectivo de pacientes con enfermedad de Méniere que consultaron entre los años 2015 y 2021. Se estudiaron los umbrales auditivos, antes y después de 3 inyecciones de dexametasona transtimpánica. Resultados: Se obtuvieron datos completos de 27 pacientes. Al comparar el promedio tonal puro antes y después del tratamiento, no se observaron diferencias significativas. A nivel individual, la variación de cambio de los umbrales auditivos con dexametasona se correlaciona en forma significativa con los umbrales auditivos previos a las inyecciones y con el tiempo transcurrido desde la última inyección, pero no con la edad. Conclusión: La terapia con dexametasona transtimpánica en pacientes con enfermedad de Méniere no altera los umbrales auditivos. Sin embargo, se requieren más estudios, para comprobar, si existe un efecto transitorio en los umbrales auditivos de los primeros días posterior al procedimiento.

Introduction: Although transtympanic corticosteroids are proposed in Méniere's disease patients refractory to standard medical therapy, the evidence regarding the effect of transtympanic corticosteroids on hearing thresholds is still controversial. Aim: To study the hearing thresholds of patients with Méniere's disease who were administrated with transtympanic corticosteroids at the Otorhinolaryngology Service of the University of Chile's Clinical Hospital. Material and Method: Retrospective study of Méniere's disease patients who consulted between 2015 and 2021. Demographic variables and hearing thresholds were studied before and after three transtympanic injections of dexamethasone. Results: A total of 27 patients were studied. There were non-significant differences in pure-tone hearing threshold averages before and after the injections. Individual variation in hearing thresholds correlates significantly with the pre-injection hearing thresholds and the period since the last injection, but not with age. Conclusion: Transtympanic dexamethasone therapy in patients with Meniere's disease does not alter hearing thresholds. However, more studies are needed to verify whether there is a transitory effect on hearing thresholds in the first days after the procedure.

Tinnitus characteristics in patients with hyperacusis and vertigo (including Ménière's disease) vs. hyperacusis alone

Introduction and objectives: To compare clinical and psychoacoustic tinnitus characteristics in patients with the comorbidity of hyperacusis, hyperacusis and vertigo, and with Ménière's disease (MD).Materials and methodsThree hundred and twenty-nine tinnitus patients underwent audiological and otoneurological evaluation. Records of 94 individuals younger than 65 years, 40 women and 54 men (mean age 41.8, range 24–64 years), who complained of tinnitus and hyperacusis, were analyzed. One hundred and thirty-one ears with tinnitus were identified: 67 in the group of patients with tinnitus and hyperacusis (group 1; 41 patients); 28 in the group fulfilling criteria of MD diagnosis (group 2; 28); and 36 in the group with tinnitus, hyperacusis and typical symptoms of vertigo (group 3; 25).Results and conclusionsMean value of interaural difference in canal paresis in group 1 was 6.3%; in group 2: 23.7%; and in group 3: 25.9%; p<.001. Mean tinnitus pitch value was significantly lower in group 3 (1679Hz; SD=1139) and group 2 (2250Hz; SD=1162) compared to group 1 (4538Hz; SD=3123; p=.012). Values of tinnitus intensity and other characteristics did not significantly differ between the groups. Tinnitus and hyperacusis were most frequently preceded by acoustic trauma. Tinnitus coinciding with hyperacusis and vertigo was observed in patients after head trauma.Mean tinnitus pitch was lower in the groups of patients with hyperacusis and peripheral labyrinthine lesion than in tinnitus sufferers with hyperacusis alone. Tinnitus sufferers with low tinnitus pitch should undergo vestibular system evaluation. Hyperacusis and vertigo are likely comorbidities in tinnitus patients after head trauma. Hyperacusis may coincide in tinnitus patients after head trauma. (AU)

Introducción y objetivos: Comparar las características clínicas y psicoacústicas del tinnitus en pacientes con comorbilidad de hiperacusia, hiperacusia y vértigo, y con enfermedad de Ménière (EM).Materiales y métodosTrescientos veintinueve pacientes con tinnitus se sometieron a evaluación audiológica y otoneurológica. Se analizaron los registros de 94 pacientes menores de 65 años, 40 mujeres y 54 hombres (edad media 41,8, rango 24-64 años), que se quejaron de tinnitus e hiperacusia. Se identificaron 131 oídos con acúfenos: 67 en el grupo de pacientes con acúfenos e hiperacusia (grupo 1; 41 pacientes); 28 en el grupo que cumplía criterios de diagnóstico de enfermedad de Ménière (grupo 2; 28); y 36 en el grupo con acúfenos, hiperacusia y síntomas típicos de vértigo (grupo 3; 25).Resultados y conclusionesEl valor medio de la diferencia interaural en paresia del canal en el grupo 1 fue del 6,3%; en el grupo 2 del 23,7%; y en el grupo 3 del 25,9%; p<0,001. El valor medio del tono del tinnitus fue significativamente menor en el grupo 3 (1679Hz; DE=1139) y el grupo 2 (2250Hz; DE=1162), en comparación con el grupo 1 (4538Hz; DE=3123; p=0,012). Los valores de la intensidad del tinnitus y otras características no difirieron significativamente entre los grupos. El tinnitus y la hiperacusia fueron precedidos con mayor frecuencia por traumatismos acústicos. Se observó tinnitus coincidente con hiperacusia y vértigo en pacientes después de traumatismo craneoencefálico.El tono medio del tinnitus es menor en los grupos de pacientes con hiperacusia y lesión laberíntica periférica que en los que padecen tinnitus con hiperacusia. (AU)

Bifenestral surgical and chemical labyrinthectomy, a new effective ablative surgical approach to intractable vertigo in Ménière disease elderly patients.

INTRODUCTION: In this article, the bi-fenestral surgical chemical labyrinthectomy is introduced as a surgical demolition technique for treating resisting incurable forms of Meniere's disease in patients aged over 70 and/or with low hearing residues refractory to medical treatment. MATERIALS AND METHODS: The results on participants fitting the inclusion criteria (n = 16) were reported using anamnesis (frequency of the crisis), Dizziness Handicap Inventory (DHI) and Functional Level Scale (FLS) before and after the intervention. RESULTS: Vertigo control was achieved in all patients of this case series. A difference of 57 and 3.67 in mean DHI (from 68 (SD 16.7) to 11 (SD 14)) and FLS (from 4.68 (SD 0.7) to 0.1 (SD 0.3)) scores respectively were seen after an average of 16.28 months. Contextually tinnitus was reported to improve in seven patients (43.75%), aggravate in three (18.75%) and remain unchanged in the remaining six (37.5%). CONCLUSION: Bi-fenestral surgical chemical labyrinthectomy appears a safe, immediate, and effective demolition treatment for vertigo control in a restricted class of patients affected by intractable Meniere disease.

Efectividad del corticoide intratimpánico en el tratamiento de la enfermedad de Ménière. Estudio de cohortes / Efectivity of intratympanic corticosteroids in the treatment of Meniere's disease. Cohort study

Introducción y objetivo: La enfermedad de Ménière (EM) es una patología auditiva crónica que se caracteriza por la presencia de hipoacusia, vértigo episódico y tinnitus. El objetivo de este estudio es valorar la mejora auditiva y la disminución de las crisis vertiginosas en pacientes con enfermedad de Ménière tras la administración de corticoide intratimpánico (CIT).Método: Estudio de cohortes retrospectivo, de una muestra de 55 pacientes diagnosticados con EM definitiva y tratados con corticoide intratimpánico.Resultados: De los 39 pacientes que fueron tratados con CIT por las crisis de vértigo, al mes, 27 no sufrieron ninguna crisis, 11 pocas (<5) y solamente 1 paciente tuvo varias crisis (5-10). A los seis meses de la primera inyección, 19 no padecieron crisis de vértigo, 13 pocas, 5 varias y 2 muchas crisis (>10). Los pacientes tratados con CIT por hipoacusia fueron 16 y reflejaron una media de pérdida auditiva de 46,61 dB previa al tratamiento. Al mes de la inyección, la media de la pérdida fue de 42,77 dB (1,84) y a los seis meses de 41,66 dB (2,95).Discusión: El beneficio audiométrico obtenido es de ?3 dB y se refleja una clara disminución del número de crisis vertiginosas tras la administración de CIT, otros autores en sus estudios han obtenido resultados similares a los nuestros.Conclusiones: Nuestros resultados evidencian que el corticoide intratimpánico es una terapia efectiva para el control de las crisis vertiginosas y la pérdida de audición. (AU)

Introduction and objective: Meniere ́s disease (MD) is a chronic auditory pathology charac-terized by the presence of hearing loss, episodic dizziness and tinnitus. The objective of this studie is to value the hearing improvement and the reduction of vertiginous crises in patients with Meniere ́s disease after the administration of intratympanic corticosteroids (ITS). Method: Retrospective cohort study of a sample of 55 patients diagnosed with definitive Meniere ́s disease and treated with intratympanic corticosteroids. Results: Of the 39 patients who were treated with ITS for vertigo attacks, one month into the treatment, 27 had no attacks, 11 experienced a few (<5) and only 1 had several attacks (5-10). Six months after the first injection, 19 had no seizures, 13 reported a few, 5 had several, and 2 manifested numerous attacks (> 10). There were 16 patients treated with ITS for hearing loss and they reflected a mean hearing loss of 46.61 dB prior to the treatment. One month after the injection, the mean loss was 42.77 dB (1.84) and at six months it was 41.66 dB (2.95). Discussion: The audiometric benefit obtained is ≈3 dB und a clear decrease in the number of vertiginous crises after ITS, other authors in their studies have obtained results similar to ours. Conclusions: Our results show that intratympanic corticosteroids is an effective therapy for the control of vertiginous crises and hearing loss. (AU)

Personality and psychopathology in Ménière's disease.

INTRODUCTION AND OBJECTIVES: Psychological factors in vertigo patients have been extensively studied but the role of anxiety and personality traits in the clinical course of Ménière's disease (MD) is unknown. The objectives of this study are to identify and characterize psychopathology in MD and to find risk factors for an increased rate and intensity of crisis and chronic symptoms. MATERIALS AND METHODS: We performed a transversal study in all patients diagnosed with definite MD in our department during a 5-year period. Sample subjects were interviewed in 3 steps: first, an otorhinolaryngologist collected information about clinical and pharmacological background of MD; second, a psychiatrist screened for mood, anxiety and personality disorders; in a third stage, the patient completed the DHI (Dizziness Handicap Inventory), STAI-Y (State Trait Anxiety Inventory), NEO-PI-R (Neo Personality Inventory Reviewed) and VAS (Visual Analogue Scale) for vertigo and dizziness. Statistical analysis was performed to search for risk factors for multiple and intense crisis and chronic symptoms. RESULTS: Thirty-four patients completed all 3 phases of the study. A predominant dysfunctional personality trait was identified in 80% of patients (predominantly cluster C type), 35% were being treated with psychiatric medication and 34.4% had a considerable mood or anxiety disorder. All patients scored high (>7) in VAS during crisis. There was a statistically significant positive correlation between crisis rate and STAI, anxiety-subscale (N1) in NEO-PI-R, VAS and DHI scores (p<.044). Crises were more common in bilateral MD (p=.041). DHI scores were higher with higher STAI and N1 (p=.001). Disease duration and pure tone average were found to have a positive moderate correlation (p=.017). CONCLUSIONS: The positive correlations between crisis rate, chronic dizziness and anxiety-related personality traits reveal a bidirectional and intimate relationship between personality, anxiety and MD, affecting these patients' quality of life. These results support the relevance of prospecting adjuvant psychological and psychiatric approaches to these patients.

Personality and psychopathology in Ménière's disease

Introduction and Objectives: Psychological factors in vertigo patients have been extensively studied but the role of anxiety and personality traits in the clinical course of Ménière's disease (MD) is unknown. The objectives of this study are to identify and characterize psychopathology in MD and to find risk factors for an increased rate and intensity of crisis and chronic symptoms.Materials and MethodsWe performed a transversal study in all patients diagnosed with definite MD in our department during a 5-year period. Sample subjects were interviewed in 3 steps: first, an otorhinolaryngologist collected information about clinical and pharmacological background of MD; second, a psychiatrist screened for mood, anxiety and personality disorders; in a third stage, the patient completed the DHI (Dizziness Handicap Inventory), STAI-Y (State Trait Anxiety Inventory), NEO-PI-R (Neo Personality Inventory Reviewed) and VAS (Visual Analogue Scale) for vertigo and dizziness. Statistical analysis was performed to search for risk factors for multiple and intense crisis and chronic symptoms.ResultsThirty-four patients completed all 3 phases of the study. A predominant dysfunctional personality trait was identified in 80% of patients (predominantly cluster C type), 35% were being treated with psychiatric medication and 34.4% had a considerable mood or anxiety disorder. All patients scored high (>7) in VAS during crisis. There was a statistically significant positive correlation between crisis rate and STAI, anxiety-subscale (N1) in NEO-PI-R, VAS and DHI scores (p<.044). Crises were more common in bilateral MD (p=.041). DHI scores were higher with higher STAI and N1 (p=.001). Disease duration and pure tone average were found to have a positive moderate correlation (p=.017). (AU)

Introducción y objetivos: Se han estudiado ampliamente los factores psicológicos en los pacientes con vértigo, pero se desconoce el rol de los rasgos de ansiedad y personalidad en el curso clínico de la enfermedad de Ménière (EM). El objetivo de este estudio es identificar y caracterizar la psicopatología en la EM, y encontrar los factores de riesgo del incremento de la tasa de crisis, intensidad de la crisis y síntomas crónicos.Materiales y métodosRealizamos un estudio transversal en todos los pacientes diagnosticados de EM definida en nuestro departamento durante un periodo de 5 años. Se entrevistó a los sujetos de la muestra en 3 pasos: en primer lugar un otorrinolaringólogo recabó información sobre los antecedentes clínicos y farmacológicos de EM; en segundo lugar, un psiquiatra determinó los trastornos emocionales, de ansiedad y personalidad y, en tercer lugar, el paciente completó las escalas Dizziness Handicap Inventory (DHI), State Trait Anxiety Inventory (STAI-Y), Neo Personality Inventory Reviewed (NEO-PI-R) y Escala analógica visual (EVA) en cuanto a vértigo y mareo. Se realizó un análisis estadístico para identificar los factores de riesgo de crisis múltiples e intensas y síntomas crónicos.ResultadosTreinta y cuatro pacientes completaron las 3 fases del estudio. Se identificó un rasgo predominante de personalidad disfuncional en el 80% de los pacientes (predominantemente el clúster tipo C), el 35% fue tratado con fármacos psiquiátricos, y el 34,4% tenía trastornos emocionales o de ansiedad notorios. Todos los pacientes tuvieron puntuaciones EVA altas (>7) durante la crisis. Existió una correlación positiva estadísticamente significativa entre la tasa de crisis y la subescala de ansiedad STAI (N1) en las escalas NEO-PI-R, EVA y DHI (p<0,044). (AU)

Prevalencia de comorbilidad depresiva en la enfermedad de Ménière

Resumen Introducción: Existe relación entre la enfermedad de Ménière (EM) y los trastornos psiquiátricos. Objetivo: Evaluar si los pacientes con EM presentan mayor prevalencia de comorbilidad depresiva en comparación a lo descrito para la población general nacional. Material y Método: Estudio analítico transversal entre los años 2009-2016, en pacientes del Servicio de Otorrinolaringología del Hospital Barros Luco Trudeau con diagnóstico de EM definitivo. Se aplicó la escala del nivel funcional para EM, tinnitus handicap inventory, test de tamizaje de depresión de Goldberg y una evaluación por psiquiatra. Resultados: Se evaluaron 64 pacientes. Promedio de edad fue 52,5 años. La prevalencia de trastorno depresivo fue 71,8%. De éstos, el 71,7% fue diagnosticado antes del estudio y el 28,3% restante durante el estudio. Conclusión: La prevalencia de comorbilidad depresiva en la EM es mayor que la descrita para la población general nacional. Determinar si la EM es la causante de esta prevalencia, o cada uno de sus síntomas por separado, requerirá de nuevos estudios.

Abstract Introduction: There is a relationship between Ménière's disease (MD) and psychiatric disorders. Aim: To assess whether MD patients have a higher prevalence of depressive comorbidity compared to that described for the national general population. Material and Method: Cross-sectional analytical study between 2009-2016, for patients seen at the Department of Otolaryngology at the Barros Luco Trudeau Hospital with a definitive MD diagnosis. The functional level scale was applied for MD, tinnitus handicap inventory, Goldberg screening for depression, and an evaluation by a psychiatrist. Results: 64 patients were evaluated. Average age was 52.5 years. The prevalence of depressive disorder was 71.8%. Of these, 71.7% were diagnosed before the study and the remaining 28.3% during the study. Conclusion: The prevalence of depressive comorbidity in MD is higher than that described for the national general population. Determine if MD or each symptom separately is the cause of this prevalence requires other studies.

Dexametasona transtimpánica para el tratamiento de la enfermedad de Ménière de difícil manejo

Resumen Introducción: La enfermedad de Ménière se caracteriza por crisis recurrentes de vértigo, asociado a hipoacusia y tinnitus, que pueden ser incapacitantes, y provocar estrés y ansiedad. Objetivos: Evaluar el efecto de la dexametasona transtimpánica sobre la audición y vértigo en pacientes con enfermedad de Ménière de difícil manejo. Material y Método: Se reclutó a pacientes con enfermedad de Ménière de difícil manejo médico quienes fueron tratados con tres inyecciones transt-impánicas de dexametasona (4 mg/ml). Se realizó audiometría, prueba calórica y dos encuestas de disca-pacidad (DHI y UCLA-DQ) al inicio, tres, y diez semanas posintervención, además de una entrevista a los seis meses. Resultados: Doce pacientes completaron el estudio. Se observó un aumento del promedio de umbrales auditivos hasta 11,25 dB, principalmente entre 125 y 3000 Hz a las tres semanas, y una reducción de éstos hasta 7,5 dB a las diez semanas respecto de los iniciales, principalmente entre 125 y 2000 Hz (no estadísticamente significativo). Todos los pacientes presentaron hipo-excitabilidad vestibular. Se observó una mejoría significativa en el puntaje de la encuesta UCLA-DQ posinterven-ción, manteniéndose durante todo el seguimiento. No se encontraron diferencias estadísticamente significativas en el puntaje global ni subcomponentes de la encuesta DHI. Siete de ocho pacientes reportaron que volverían a utilizar las inyecciones. Conclusión: Los corticoides transtimpánicos pueden ayudar a disminuir la discapacidad e impacto en la calidad de vida de los pacientes con enfermedad de Ménière de difícil manejo a mediano y largo plazo.

Abstract Introduction: Ménière's disease is characterized by recurrent episodes of vertigo, sensorineural hearing loss and aural fullness, which can be incapacitating and cause stress and anxiety. Aim: To assess the effect of transtympanic steroid injections on hearing and vertigo for patients suffering from intractable Ménière's disease. Material and Method: Patients with intractable Ménière's disease were recruited and treated with three transtympanic steroid injections (dexamethasone 4 mg/ml). Audiometric and vestibular assessment, and two dizziness questionnaires (DHI, UCLA-DQ) were performed upon recruitment, three weeks, and ten weeks following the transtympanic treatment. A brief auto-perception survey was applied at 6 months follow-up. Results: Twelve patients completed the study. An increase in the mean auditory threshold was observed up to 11.25 dB, mainly between 125 and 3000 Hz at three weeks, and a reduction of these up to 7.5 dB at ten weeks with respect to the initial ones, mainly between 125 and 2000 Hz (not statistically significant). All patients presented vestibular dysfunction on caloric testing. A significant impro-vement in the UCLA-DQ survey score was observed, remaining throughout the follow-up. No statistically significant differences were found in the overall score or subcomponents of the DHI. Seven out of eight patients reported that they would undergo the injections again. Conclusion: Transtympanic corticosteroids can help to reduce disability and impact on the quality of life of patients with Ménière's disease that is difficult to manage in the medium and long term.

Síndrome de Lermoyez, presentación de caso clínico / Lermoyez´s syndrome, a case report presentation

Lermoyez´ syndrome is an unusual clinical variant of Ménière's disease, because in both pathologies there is a peripheral vascular disorder, what It consists in the dilation of the labyrinthine membranes associated with an increase in the volume of the endolymph. Clinically, they have severe frequency fluctuations of hearing loss, tinnitus and vertigo attacks. FinaIly, it evolves to the deterioration of hearing in all frequencies. Lermoyez´ síndrome, or labyrinthine angiospasm, has an unknown etiopathogeny, although several theories have been proposed, but none explains its nature, nor its clinical course, being one of them the allergy. Their diagnosis is clinical, they present the typical triad (peripheral vertigo crisis with neurosensory hearing loss and tinnitus and/or otic fullness), but they characterised by the improvement in hearing just after a sudden vertigo attack. With the development of the disease, dizziness attacks and hearing recovery become more and more rare, and disappear. Treatment aims to relieve symptoms during crises and improve disease progression. It is present the clinical case of Lermoyez syndrome, in a male patient with allergic pathology, who was diagnosed with Ménière's disease at the beginning. It is a rare syndrome described described in classical ENT (ear-nose-throat)

El síndrome de Lermoyez es una variante clínica inusual de la enfermedad de Ménière. En ambas afecciones existe un trastorno vascular periférico, que consiste en la dilatación de las membranas laberínticas, asociadas con aumento del volumen de la endolinfa. Clínicamente, el individuo presenta fluctuaciones en la audición (hipoacusia neurosensorial en las frecuencias graves), acúfenos y ataques de vértigo. En su evolución final se deteriora la audición en todas las frecuencias. El síndrome de Lermoyez, o angioespasmo laberíntico, tiene una etiopatogenia desconocida, aunque se han propuesto varias teorías, pero ninguna explica su naturaleza ni su curso clínico, y una de ellas es la alergia. Su diagnóstico es clínico, presentan la triada típica (crisis de vértigo periférico con hipoacusia neurosensorial y acúfenos o plenitud ótica), pero el síndrome de Lermoyez se caracteriza por la mejora de la audición tras un ataque brusco de vértigo. Con el avance de la enfermedad, los ataques de vértigo y la recuperación de la audición llegan a ser cada vez más raros, hasta desaparecer. El tratamiento tiene como finalidad aliviar los síntomas durante las crisis y mejorar la evolución de la enfermedad. Se presenta un caso clínico de síndrome de Lermoyez, en un paciente varón con afección alérgica, cuyo diagnóstico de inicio fue de enfermedad de Ménière. Es un síndrome infrecuente, descrito en la otorrinolaringología clásica

Resonancia magnética en enfermedad de Ménière

Resumen La enfermedad de Ménière (EM) es una conocida causa de vértigo crónico asociado a múltiples síntomas audiológicos fluctuantes (hipoacusia, tinnitus, plenitud aural). Su fisiopatología no es completamente comprendida, pero se ha relacionado al hidrops endolinfático (HE) como entidad principal. A la fecha, varios estudios electrofisiológicos han intentado posicionarse como pruebas diagnósticas definitivas, pero no lo han logrado, ya sea por dificultad técnica para realizarlos o por resultados inconsistentes en la literatura internacional. Pero cabe destacar que varios hallazgos son altamente sugerentes de enfermedad de Ménière como la presencia de una baja tasa de respuesta asociado al aumento del umbral de esta misma en los VEMPs (vestibular evoked myogenic potentials), tanto oculares como cervicales, o el aumento del cuociente entre el potencial de sumación/potencial de acción en la electrococleografía. A pesar de estas pruebas, hasta el día de hoy, el diagnóstico se sigue realizando en base a criterios clínicos consensuados internacionalmente, dado lo dificultosa que es la visualización directa del HE y falta de compresión de otros mecanismos fisiopatológicos de esta enfermedad. En las últimas décadas, ha habido avances prometedores en la detección de hidrops endolinfático con el uso de resonancia magnética, permitiendo la visualización de los espacios peri y endolinfáticos usando gadolinio como contraste. A su vez, esto ha permitido mejoría de las secuencias imagenológicas usadas, el desarrollo de varias nuevas técnicas de procesamiento de imágenes, conllevando que varias escalas o clasificaciones de HE hayan sido propuestas, las cuales serán revisadas en detalle en este trabajo.

Abstract Ménière's disease (MD) is a known cause of chronic vertigo, with multiple fluctuating audiological symptoms (hearing loss, tinnitus, aural fullness). The pathophysiology is not completely understood but has been attributed to endolymphatic hydrops (EH). There are many electrophysiological tests available, but none of them can be considered as the gold standard, either because of difficult technique or inconsistent results in the literature. Nonetheless, some findings are highly suggestive of MD, like the presence of a low response and high threshold in ocular and cervical VEMPs (vestibular evoked myogenic potentials), or the increased ratio between the amplitudes of summation potential and action potential in the electrocochleography. Despite the availability of these tests, the diagnosis of MD is still made clinically, following the diagnostic criteria establish by international consensus, due to the difficulty to visualize the EH and also the lack of full comprehension of other pathophysiological mechanisms. In the last decades, there have been promising advances in the detection of endolymphatic hydrops with magnetic resonance imaging, allowing the visualization of the perilymphatic and endolymphatic space using gadolinium as a contrast agent. At the same time, the imaging sequences have improved, new techniques for imaging processing have been developed, entailing that various classifications or graduation systems for EH have been proposed, which will be review in detail, in this paper.

Personality and psychopathology in Ménière's disease.

INTRODUCTION AND OBJECTIVES: Psychological factors in vertigo patients have been extensively studied but the role of anxiety and personality traits in the clinical course of Ménière's disease (MD) is unknown. The objectives of this study are to identify and characterize psychopathology in MD and to find risk factors for an increased rate and intensity of crisis and chronic symptoms. MATERIALS AND METHODS: We performed a transversal study in all patients diagnosed with definite MD in our department during a 5-year period. Sample subjects were interviewed in 3 steps: first, an otorhinolaryngologist collected information about clinical and pharmacological background of MD; second, a psychiatrist screened for mood, anxiety and personality disorders; in a third stage, the patient completed the DHI (Dizziness Handicap Inventory), STAI-Y (State Trait Anxiety Inventory), NEO-PI-R (Neo Personality Inventory Reviewed) and VAS (Visual Analogue Scale) for vertigo and dizziness. Statistical analysis was performed to search for risk factors for multiple and intense crisis and chronic symptoms. RESULTS: Thirty-four patients completed all 3 phases of the study. A predominant dysfunctional personality trait was identified in 80% of patients (predominantly cluster C type), 35% were being treated with psychiatric medication and 34.4% had a considerable mood or anxiety disorder. All patients scored high (>7) in VAS during crisis. There was a statistically significant positive correlation between crisis rate and STAI, anxiety-subscale (N1) in NEO-PI-R, VAS and DHI scores (p<.044). Crises were more common in bilateral MD (p=.041). DHI scores were higher with higher STAI and N1 (p=.001). Disease duration and pure tone average were found to have a positive moderate correlation (p=.017). CONCLUSIONS: The positive correlations between crisis rate, chronic dizziness and anxiety-related personality traits reveal a bidirectional and intimate relationship between personality, anxiety and MD, affecting these patients' quality of life. These results support the relevance of prospecting adjuvant psychological and psychiatric approaches to these patients.

Laberintectomía quirúrgica e implante coclear simultáneo en paciente con enfermedad de Ménière bilateral / Simultaneous labyrinthectomy with cochlear implantation in a patient with bilateral Ménière's disease

Los pacientes con enfermedad de Ménière representan un desafío terapéutico para el médico tratante, especialmente cuando no responden al tratamiento médico conservador. Presentamos un caso de un paciente de 45 años con enfermedad de Ménière activa en oído izquierdo sometido a laberintectomía quirúrgica con implante coclear simultáneo en dicho oído. Se evaluaron resultados clínicos y audiométricos en un seguimiento de 9 meses posencendido del implante y el paciente presentó PTP de 21 dB, con 92% de discriminación a disílabos a 45 dB en el oído implantado, sin tinnitus ni síntomas vestibulares. La combinación de laberintectomía con implante coclear en un mismo tiempo quirúrgico, fue efectiva en controlar los síntomas vestibulares y audiológicos del paciente estudiado.

Patients with Méniére's disease represent a therapeutical problem for physicians, especially in those who do not respond to conservative approaches. We report the case of a 45-year-old male with bilateral Ménière's disease, active in the left ear, who underwent simultaneous cochlear implantation combined with labyrinthectomy surgery. Audiometric and clinical results were evaluated, 9 months after the activation of the implant the patient's PTA was 21 dB, with 92% disyllabic word's discrimination at 45 dB in the implanted ear, without tinnitus or vestibular symptoms. The combined surgical labyrinthectomy and cochlear implantation are efficient for the treatment of vestibular and audiological symptoms of the patient.

Enfoque diagnóstico del síndrome vestibular agudo en urgencias / Integral approach of acute vestibular síndrome

RESUMEN El vértigo se define como una sensación rotacional de movimiento y es uno de los principales motivos de consulta en urgencias. Aproximadamente entre el 5 y 7% de los pacientes que asisten a consulta de Medicina General han presentado esta afección en el último año. Por este motivo, es necesario tener una adecuada orientación de los casos que permita identificar su causa y diferenciar entre la patología central y periférica lo que permitirá abordar los pacientes de una manera adecuada, que permita distinguir aquellos que requieran hospitalización para estudios complementarios de los que pueden ser manejados ambulatoriamente. A continuación, revisaremos los principales síntomas clínicos, las pruebas semiológicas más utilizadas y las etiologías más relevantes para describir un abordaje sencillo de este síndrome.

SUMMARY Vertigo is defined as a sensation of rotation or imbalance and is a common complain for emergency room consultation. Approximately between 5% and 7% of patients who consulted their general physician in the last year have presented vertigo. Therefore, it is essential to have an adequate understanding of this disease to properly distinguish between the principal causes as it orients proper treatment. This article is a review of the main symptoms, frequently used clinical exams and relevant etiologies, in order to provide a simple orientation to general practitioners.

Uso de gentamicina transtimpánica: experiencia del Hospital Clínico de la Universidad de Chile / Transtympanic gentamicin: experience in Hospital Clínico Universidad de Chile

RESUMEN Introducción: La gentamicina transtimpánica se utiliza en el manejo de pacientes con vértigo crónico refractario al manejo médico. Objetivo: Describir y analizar las características clínicas, epidemiológicas, y resultados de pacientes sometidos a tratamiento con gentamicina transtimpánica en el Hospital Clínico de la Universidad de Chile. Material y método: Estudio retrospectivo, descriptivo, incluyendo los pacientes con patología otorrinolaringológica que hayan recibido gentamicina transtimpánica entre los años 2008 y 2018. Se analizaron variables epidemiológicas, clínicas, y función vestibular. Resultados: La serie está constituida por diez pacientes, con una edad promedio de 52,4 años; siete mujeres y tres hombres. El diagnóstico fue en su mayoría enfermedad de Ménière (7 pacientes). El número promedio de inyecciones de gentamicina fue de 2,8. En el período de seguimiento (rango 1-96 meses), se logró mejoría del vértigo en la mayoría de los pacientes (8 de 10). Conclusión: El tratamiento con inyecciones de gentamicina transtimpánica es una opción importante para aliviar la sintomatología de pacientes con vértigo crónico intratable. Debe indicarse en casos seleccionados, y siempre realizar un estudio auditivo y vestibular completo antes y después del tratamiento con gentamicina.

ABSTRACT Introduction: Transtympanic gentamicin is used for treatment of patients with chronic vertigo refractory to medical management. Aim: To describe and analyze the clinical outcome of patients whom underwent treatment with transtympanic gentamicin at the Clinical Hospital Universidad de Chile. Material and method: Retrospective and descriptive study including patients with otolaryngologist disease whom underwent treatment with transtympanic gentamicin between 2008 and 2018. Epidemiological, clinical variables and vestibular function were analyzed. Results: The serie consists of ten patients, 7 men and 3 women, with an average age of 52,4 years. The most frequent diagnosis was Ménière disease (7 patients). The average number of gentamicin injections was 2,8. The follow up varies from 1 to 96 months, presenting improvement of vertigo in the majority of the cases (8 of 10 patients). Conclusion: The treatment with transtympanic injections of gentamicin is a relevant option to decrease symptoms in patients with chronic intractable vertigo. It should be indicated in selected patients. Prior and posterior the treatment, patients must be studied with a complete evaluation of the auditory and vestibular function.

Immune-Mediated Inner Ear Disease: Diagnostic and therapeutic approaches.

INTRODUCTION: Immune Mediated Inner Ear Disease (IMIED) is a rare form of sensorineural bilateral hearing loss, usually progressing in weeks to months and responsive to immunosuppressive treatment. Despite recent advances, there is no consensus on diagnosis and optimal treatment. METHODS: A review of articles on IMIED from the last 10 years was conducted using PubMed® database. RESULTS: IMIED is a rare disease, mostly affecting middle aged women. It may be a primary ear disease or secondary to autoimmune systemic disease. A dual immune response (both cellular and humoral) seems to be involved. Cochlin may be the inner ear protein targeted in this disease. Distinction from other (core common) forms of neurosensory hearing loss is a challenge. Physical examination is mandatory for exclusion of other causes of hearing loss; audiometry identifies characteristic hearing curves. Laboratory and imaging studies are controversial since no diagnostic marker is available. CONCLUSION: Despite recent research, IMIED diagnosis remains exclusive. Steroids are the mainstay treatment; other therapies need further investigation. For refractory cases, cochlear implantation is an option and with good relative outcome.

Rehabilitación vestibular de la Enfermedad de Meniere en el estadio tardío: Reporte de un caso / Vestibular rehabilitation of Meniere's Disease in its chronic stage: A case report

La enfermedad de Meniere (EM), se caracteriza por ataques fluctuantes de vértigos, hipoacusia y acúfenos. Una vez que se controlan los síntomas agudos, la rehabilitación vestibular es una alternativa de tratamiento efectiva. Se presenta el caso de una mujer de 46 años con EM en la fase crónica que presenta persistencia de vértigo postural e inestabilidad de la marcha, quien fue intervenida con maniobras de reposición y rehabilitación vestibular con ejercicios de adaptación y sustitución, ejercicios de habituación del equilibrio vestibular y de control postural. Se obtuvo una respuesta favorable, con desaparición del vértigo posicional, disminución significativa de la inestabilidad y gran mejoría en su calidad de vida. No se puede llegar a conclusiones con un solo caso, sin embargo, es importante el abordaje integral en el tratamiento de pacientes con EM. (AU)

Meniere's disease presents fluctuating attacks of dizziness, hearing loss and tinnitus. Once acute symptoms are controlled, vestibular rehabilitation is an effective treatment alternative. We present the case of a 46-year-old woman with Meniere's disease in the chronic phase, who presented persistent postural vertigo and gait instability and who was treated with repositioning maneuvers, along with vestibular rehabilitation with adaptation, substitution and habituation exercises, vestibular balance and postural control. A favorable response is achieved, with the disappearance of positional vertigo, a significant decrease in instability and a great improvement in her quality of life. No conclusions can be drawn from a single case; however, a comprehensive approach is important in the treatment of patients with MS. (AU)

Laberintectomía quirúrgica / Surgical labyrinthectomy

El tratamiento quirúrgico del vértigo se puede dividir en dos grandes grupos: no ablativos y ablativos, dentro de éstos últimos se encuentra la laberintectomía quirúrgica, técnica con la cual se produce cofosis. Su principal indicación es la sintomatología vestibular periférica invalidante, unilateral, que no mejora con medidas farmacológicas ni con terapia psiquiátrica, asociado a hipoacusia sensorioneural severa a profunda. Existen dos tipos de abordajes para realizar la laberintectomía quirúrgica: transmastoidea y transcanal, siendo la primera el gold standard para eliminar la función vestibular. Se presentarán dos casos clínicos de pacientes sometidos a estos procedimientos, uno por vía transmastoidea y otro por vía transcanal.

The surgical treatment of vertigo can be classified into two main groups: non-ablative and ablative. The surgical labyrinthectomy is an ablative treatment in which no hearing is preserved. Its main indication is the disabling peripherical and unilateral vestibular symptoms that do not improve with pharmacological measures or with psychiatric therapy, in patients with severe to profound sensorineural hearing loss. There are two types of approaches for labyrinthectomy, transmastoid and transcanal, the first is the gold standard to eliminate the vestibular function. Here, we present two cases of patients undergoing these procedures, one by transmastoid approach and the other by transcanal approach.